Literature DB >> 25502590

The new ACC/AHA guidelines on the treatment of dyslipidemia: cons.

Alberto Zambon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25502590     DOI： 10.1007/s11739-014-1165-5

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  11 in total

1.  Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.

Authors:  Maryam Kavousi; Maarten J G Leening; David Nanchen; Philip Greenland; Ian M Graham; Ewout W Steyerberg; M Arfan Ikram; Bruno H Stricker; Albert Hofman; Oscar H Franco
Journal:  JAMA       Date:  2014-04-09       Impact factor: 56.272

2.  Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.

Authors:  Luca Degli Esposti; Stefania Saragoni; Paolo Batacchi; Silvia Benemei; Pierangelo Geppetti; Alessandra Sturani; Stefano Buda; Ezio Degli Esposti
Journal:  Clin Ther       Date:  2012-01       Impact factor: 3.393

Review 3.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

4.  Statins: new American guidelines for prevention of cardiovascular disease.

Authors:  Paul M Ridker; Nancy R Cook
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321

5.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

6.  Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk.

Authors:  Pythia T Nieuwkerk; Melchior C Nierman; Maud N Vissers; Mirjam Locadia; Phillip Greggers-Peusch; Léon P M Knape; John J P Kastelein; Mirjam A G Sprangers; Hanneke C de Haes; Erik S G Stroes
Journal:  Am J Cardiol       Date:  2012-05-22       Impact factor: 2.778

7.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

Review 8.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

Review 9.  Interventions for helping patients to follow prescriptions for medications.

Authors:  R B Haynes; H McDonald; A X Garg; P Montague
Journal:  Cochrane Database Syst Rev       Date:  2002

10.  The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011.

Authors:  Kausik K Ray; John J P Kastelein; S Matthijs Boekholdt; Stephen J Nicholls; Kay-Tee Khaw; Christie M Ballantyne; Alberico L Catapano; Željko Reiner; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2014-03-17       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.